Technical Analysis for ARCT - Arcturus Therapeutics Ltd.

Grade Last Price % Change Price Change
grade F 6.15 -1.28% -0.08
ARCT closed down 1.28 percent on Monday, May 20, 2019, on 49 percent of normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.

Earnings due: May 30

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical ARCT trend table...

Date Alert Name Type % Chg
200 DMA Resistance Bearish 0.00%
Shooting Star Candlestick Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Doji - Bearish? Reversal 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
200 DMA Resistance Bearish -1.28%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.28%
Wide Bands Range Expansion -1.28%
Oversold Stochastic Weakness -1.28%

Older signals for ARCT ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Alcobra Ltd is a development-stage biopharmaceutical company. The Company is focused on development and commercialization of its lead product candidates, including MDX and ADAIR. MDX is a oral drug, for the treatment of ADHD and other cognitive disorders, including Fragile X. MDX is a combined rapid onset ER formulation of the chemical pyridoxine pyroglutamate, which is more commonly known as metadoxine. MDX consists of a single bi-layer oral tablet, which includes both a rapid onset release metadoxine formulation and a slow release metadoxine formulation together providing the desired dual release profile. The new extended-release formulation prolongs the human plasma levels of metadoxine for up to 12 hours, which results in enhanced efficacy benefits. ADAIR is an oral, semi-solid, liquid-filled, hard gelatin capsule of an abuse-deterrent IR formulation of dextroamphetamine sulfate, which is manufactured as 10 mg capsules.
Biopharmaceutical Pharmaceutical Industry Drugs Pharmacology Health Sciences Euphoriants Dosage Forms Cognitive Disorders Adhd Tablet
Is ARCT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 10.0
52 Week Low 4.11
Average Volume 53,269
200-Day Moving Average 6.4718
50-Day Moving Average 6.7285
20-Day Moving Average 6.9216
10-Day Moving Average 6.364
Average True Range 0.4867
ADX 23.39
+DI 15.9365
-DI 20.846
Chandelier Exit (Long, 3 ATRs ) 6.9399
Chandelier Exit (Short, 3 ATRs ) 7.1601
Upper Bollinger Band 8.2803
Lower Bollinger Band 5.5629
Percent B (%b) 0.22
BandWidth 39.259709
MACD Line -0.2761
MACD Signal Line -0.1341
MACD Histogram -0.142
Fundamentals Value
Market Cap 974.74 Million
Num Shares 158 Million
EPS -0.56
Price-to-Earnings (P/E) Ratio -10.98
Price-to-Sales 11.42
Price-to-Book 2.04
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.89
Resistance 3 (R3) 6.96 6.78 6.76
Resistance 2 (R2) 6.78 6.60 6.75 6.72
Resistance 1 (R1) 6.47 6.48 6.63 6.40 6.68
Pivot Point 6.29 6.29 6.37 6.26 6.29
Support 1 (S1) 5.98 6.11 6.14 5.91 5.62
Support 2 (S2) 5.80 5.99 5.77 5.58
Support 3 (S3) 5.49 5.80 5.54
Support 4 (S4) 5.42